or Try an Advanced Search...

    Technical Analysis for LIPO - Lipella Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    F 0.72 0.64% 0.00
    LIPO closed up 0.64 percent on Friday, April 19, 2024, on 9 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical LIPO trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Fell Below 20 DMA Bearish 0.64%
    Inside Day Range Contraction 0.64%
    Gapped Down Weakness 0.64%
    20 DMA Support Bullish -4.15%
    Stochastic Reached Overbought Strength -4.15%
    Weak + Overbought Other -4.15%
    Older End-of-Day Signals for LIPO ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 14 hours ago
    Possible Inside Day about 14 hours ago
    20 DMA Resistance about 16 hours ago
    Rose Above 20 DMA about 17 hours ago
    Up 1% about 17 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    LIPO Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Lipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. We believe that this strategy combines many of the cost efficiencies and risk abatements derived from using existing generic drugs with potential patent protections for our proprietary formulations; this strategy allows us to expedite, protect, and monetize our product candidates. Additionally, we maintain a therapeutic focus on diseases with significant, unaddressed morbidity and mortality where no approved drug therapy currently exists, believing that this focus can potentially help reduce the cost, time and risk associated with obtaining marketing approval.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Disease Drug Therapy Generic Drug

    Is LIPO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 7 PRISM MarketView Spotlights Lipella Pharmaceuticals as it Seizes Opportunities in Rare Disease
    Mar 5 Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline
    Feb 20 Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference
    Nov 10 Lipella's oral GvHD drug candidate gets orphan designation
    Nov 10 FDA Grants Orphan Designation for Lipella's LP-310 Drug Candidate for Oral Graft-versus-Host Disease
    Oct 25 Lipella Pharmaceuticals Announces Closing of $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules
    Oct 24 Lipella Pharmaceuticals stock plummets on $2M private placement priced ATM
    Oct 24 Lipella Pharmaceuticals Announces $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules
    Oct 23 Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference
    Oct 20 Gold Rises Over 1%; Schlumberger Shares Fall After Q3 Results
    See more LIPO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.71
    52 Week Low 0.64
    Average Volume 72,334
    200-Day Moving Average 1.32
    50-Day Moving Average 0.82
    20-Day Moving Average 0.72
    10-Day Moving Average 0.73
    Average True Range 0.06
    RSI (14) 44.75
    ADX 10.34
    +DI 19.71
    -DI 16.96
    Chandelier Exit (Long, 3 ATRs) 0.64
    Chandelier Exit (Short, 3 ATRs) 0.81
    Upper Bollinger Bands 0.77
    Lower Bollinger Band 0.67
    Percent B (%b) 0.49
    BandWidth 14.30
    MACD Line -0.02
    MACD Signal Line -0.03
    MACD Histogram 0.0097
    Fundamentals Value
    Market Cap 4.35 Million
    Num Shares 6.05 Million
    EPS -0.74
    Price-to-Earnings (P/E) Ratio -0.97
    Price-to-Sales 12.62
    Price-to-Book 2.72
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.75
    Resistance 3 (R3) 0.75 0.74 0.74
    Resistance 2 (R2) 0.74 0.73 0.74 0.74
    Resistance 1 (R1) 0.73 0.72 0.72 0.73 0.74
    Pivot Point 0.72 0.72 0.71 0.72 0.72
    Support 1 (S1) 0.71 0.71 0.70 0.71 0.70
    Support 2 (S2) 0.70 0.70 0.70 0.69
    Support 3 (S3) 0.69 0.70 0.69
    Support 4 (S4) 0.69